Yan Liu, MD, MS, PhD, is Median’s Chief Medical Officer. She is responsible for managing Medical Affairs of the company, supporting Median’s clinical trials operations and all additional medical activities related to the development of the Median’s Imaging Phenomics platform iBiopsy®. Dr. Yan Liu is an imaging expert with more than 15 years of clinical and academic research experience. For the past 6 years, Dr. Liu has been dedicated to the integration of imaging in multicenter oncology trials and the validation of imaging biomarkers. Previously, Dr. Liu served as the head of translational research, radiotherapy and imaging department of the European Organisation for Research and Treatment of Cancer (EORTC). Dr. Liu completed her medical studies at the Shanghai Jiaotong University College of Medicine, China, where she received her Master of Medicine in Image Diagnosis as well. Dr. Liu also studied brain functional imaging at the Erasmus Hospital in Brussels, where she earned her PhD in medical science (neuroradiology) from Université Libre de Bruxelles. Dr. Liu has published book chapters and more than 30 peer-reviewed papers in high impact journals such as Lancet Oncology and Nature Reviews Clinical Oncology. Before joining Median, Dr. Liu was a member of the RECIST core working group, the scientific leader of two European imaging projects, and the chair for the EORTC imaging group (2016-2017).